Literature DB >> 30590116

Regulation of endothelial barrier integrity by redox-dependent nitric oxide signaling: Implication in traumatic and inflammatory brain injuries.

Seungho Choi1, Nishant Saxena1, Tajinder Dhammu1, Mushfiquddin Khan1, Avtar K Singh2, Inderjit Singh3, Jeseong Won4.   

Abstract

Nitric oxide (NO) synthesized by eNOS plays a key role in regulation of endothelial barrier integrity but underlying cell signaling pathway is not fully understood at present. Here, we report opposing roles of two different redox-dependent NO metabolites; peroxynitrite (ONOO-) vs. S-nitrosoglutathione (GSNO), in cell signaling pathways for endothelial barrier disruption. In cultured human brain microvessel endothelial cells (hBMVECs), thrombin induced F-actin stress fiber formation causes barrier disruption via activating eNOS. Thrombin induced eNOS activity participated in cell signaling (e.g. RhoA and calcium influx mediated phosphorylation of myosin light chain) for F-actin stress fiber formation by increasing ONOO- levels. On the other hand, thrombin had no effect on intracellular levels of S-nitrosoglutathione (GSNO), another cellular NO metabolite. However, exogenous GSNO treatment attenuated the thrombin-induced cell signaling pathways for endothelial barrier disruption, thus suggesting the role of a shift of NO metabolism (GSNO vs. ONOO-) toward ONOO- synthesis in cell signaling for endothelial barrier disruption. Consistent with these in vitro studies, in animal models of traumatic brain injury and experimental autoimmune encephalomyelitis (EAE), ONOO- scavenger treatment as well as GSNO treatment were effective for attenuation of BBB leakage, edema formation, and CNS infiltration of mononuclear cells. Taken together, these data document that eNOS-mediated NO production and following redox-dependent NO metabolites (ONOO- vs. GSNO) are potential therapeutic target for CNS microvascular disease (traumatic and inflammatory) pathologies.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Actin stress fiber; Brain endothelial barrier; Endothelial nitric oxide synthase (eNOS); Nitric oxide; Peroxynitrite (ONOOˉ); S-nitrosoglutathione (GSNO)

Mesh:

Substances:

Year:  2018        PMID: 30590116      PMCID: PMC6546177          DOI: 10.1016/j.niox.2018.12.007

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  6 in total

1.  Angiotensin II-induced endothelial dysfunction: Impact of sex, genetic background, and rho kinase.

Authors:  Dale A Kinzenbaw; Lucy Langmack; Frank M Faraci
Journal:  Physiol Rep       Date:  2022-06

Review 2.  Hydroxyethylstarch revisited for acute brain injury treatment.

Authors:  Martin A Schick; Malgorzata Burek; Carola Y Förster; Michiaki Nagai; Christian Wunder; Winfried Neuhaus
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

3.  Piezo1 acts upstream of TRPV4 to induce pathological changes in endothelial cells due to shear stress.

Authors:  Sandip M Swain; Rodger A Liddle
Journal:  J Biol Chem       Date:  2020-12-14       Impact factor: 5.157

4.  Vascular and immunopathological role of Asymmetric Dimethylarginine (ADMA) in Experimental Autoimmune Encephalomyelitis.

Authors:  Inderjit Singh; Judong Kim; Nishant Saxena; Seungho Choi; S M Touhidul Islam; Avtar K Singh; Mushfiquddin Khan; Jeseong Won
Journal:  Immunology       Date:  2021-08-02       Impact factor: 7.397

5.  Evaluation of Gas Explosion Injury Based on Analysis of Rat Serum Profile by Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabonomics Techniques.

Authors:  Xinwen Dong; Weidong Wu; Sanqiao Yao; Jia Cao; Ling He; Houcheng Ren; Wenjie Ren
Journal:  Biomed Res Int       Date:  2020-07-28       Impact factor: 3.411

Review 6.  Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?

Authors:  Márta L Debreczeni; Zsuzsanna Németh; Erika Kajdácsi; Henriette Farkas; László Cervenak
Journal:  Clin Rev Allergy Immunol       Date:  2021-03-16       Impact factor: 8.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.